Categories: EHRNewsPharmaceutical

Boehringer Ingelheim announces appointment to Board of Managing Directors

Harsha Deshmukh

Harsha Deshmukh

  • Harsha Deshmukh has been appointed a member of the Board of Managing Directors with responsibility for IT and Global Business Services effective 1 February 2026 

Boehringer Ingelheim announced today that the Shareholders’ Committee has appointed Harsha Deshmukh to the Board of Managing Directors. Effective 1 February 2026, Harsha Deshmukh will lead the IT and Global Business Services functions focusing on digital transformation and driving the further development of business services at the company. IT and Global Business Services, which so far were part of the Group Functions Division, will be set up as a separate Board Division. 

Commenting on the appointment, Hubertus von Baumbach, Chairman of the Boehringer Shareholders’ Committee said: “We warmly welcome Harsha Deshmukh. With his extensive experience in fostering innovation, he will help drive our journey of transformation – a transformation in the interest of patients. We know that in this process of continuous improvement we can rely on the proven skills, the contributions and the high commitment of each individual in our organization.” 

Chairman of the Board of Managing Directors Shashank Deshpande added: “I am excited to welcome Harsha to Boehringer Ingelheim. His appointment strengthens our capabilities in the important segments of IT and services, two areas that are critical elements to underpin our future growth.” 

Harsha Deshmukh will join Boehringer Ingelheim from Infineon Technologies AG in Munich, where he most recently was Executive Vice President & Chief Information Officer. He holds degrees in Electronics, Human Resources and Global Management from the University of Mumbai, Babson College and INSEAD. 

Harsha Deshmukh 

Diploma Engineering and Industrial Electronics, MBA Human Resources Management (University of Mumbai), Global Management (Babson College and INSEAD) 

Professional milestones 

2021 – present Executive Vice President & Chief Information Officer, Infineon Technologies AG, Munich, Germany 

2009 – 2021 Senior Vice President Information Technology, Infineon Technologies AG, Munich, Germany 

2001 – 2009 Director of Supply Chain Applications, Infineon Technologies, Munich, Germany 

1999 – 2001 Senior Consultant Advanced Planning Systems, Siemens Information Management Systems, Mumbai, India 

1989 – 1999 Manager Manufacturing Automation, Mukand Ltd., Mumbai, India 

About Boehringer Ingelheim 

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.

Attachment

Staff

Recent Posts

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

50 minutes ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

2 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

2 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

2 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

7 hours ago

Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 16, 2026 /PRNewswire/…

8 hours ago